Brief: Acelrx Enters Into Licensing Agreement For DZUVEO In Europe

Talphera

14/07/2021 13:33

July 14 (Reuters) - AcelRx Pharmaceuticals Inc  ACRX.O :
    * ACELRX ENTERS INTO LICENSING AGREEMENT FOR DZUVEO® IN
EUROPE AND
IN-LICENSING AGREEMENT FOR TWO PRODUCTS IN THE U.S.
    * ACELRX PHARMACEUTICALS INC - AGUETTANT WILL HAVE RIGHT TO
COMMERCIALIZE DZUVEO IN EUROPE
    * ACELRX PHARMACEUTICALS INC - ACELRX IS ENTITLED TO RECEIVE
UP TO
APPROXIMATELY $55 MILLION IN A COMBINATION OF UP-FRONT AND
SALES-BASED MILESTONE PAYMENTS
    * ACELRX PHARMACEUTICALS INC - ACELRX WILL MANUFACTURE AND
SUPPLY
DZUVEO TO AGUETTANT AT AN AGREED SUPPLY PRICE

Source text for Eikon:  ID:nPn5h1kX5a 
Further company coverage:  ACRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))